Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992;42(6):623-7.
doi: 10.1007/BF00265926.

In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan

Affiliations

In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan

M Tani et al. Eur J Clin Pharmacol. 1992.

Abstract

The in vitro effect of lentinan in inducing activation of killer cells and cytotoxic macrophages has been examined. Human peripheral blood mononuclear cells were cultured with lentinan for 2, 4 and 8 days. After 4 days cytotoxicity was increased 4% by lentinan less than 1,000 ng/ml. After 8 days, it was increased 12% by 25 and 1,000 ng/ml lentinan. The phenotype of the killer cells induced by lentinan was CD2+, CD16+ and CD56+, suggesting that they were natural killer cells. Macrophages separated from the spleens of 6 patients with gastric cancer were cultured with lentinan for 7 days, and their cytotoxicity increased 19%. The optimal concentration of lentinan was from 25 to 100 ng/ml. The findings suggest that the antitumour effect of lentinan is due to the activation of killer cells in vivo, because the optimal concentration of lentinan for the induction of killer cells in vitro was equivalent to the plasma concentration obtained after clinical doses of this agent.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1985 Aug;135(2):1145-52 - PubMed
    1. Nature. 1969 May 17;222(5194):687-8 - PubMed
    1. Cancer Res. 1984 Nov;44(11):5132-7 - PubMed
    1. Cancer Treat Rep. 1986 Jan;70(1):171-82 - PubMed
    1. Int J Cancer. 1988 Sep 15;42(3):428-34 - PubMed

MeSH terms

LinkOut - more resources